Sanofi-Aventis U.S. LLC
FDA Registration(s)#
Registration, FEI, Name table| Registration | FEI | Name | Status | Initial importer | Expiration year | Address |
|---|
| 3003496686 | 3000719690 | Sanofi-Aventis U.S. LLC | 1 | N | 2020-04-25 | 55 Corporate Drive BRIDGEWATER NJ US 08807 |
Registered Device Listings#
Registration key, Listing key, Premarket submission table| Registration key | Listing key | Premarket submission | Device | Product code | Decision date |
|---|
| 61505 | 1804950956 | K131159 | SMARTRELIEF | NUH | 2013-07-25 |
Product Codes Associated With Registrations#
Product code, Registration listing records, Latest decision table| Product code | Registration listing records | Latest decision |
|---|
| NUH | 1 | 2013-07-25 |
NDC#
Sanofi-Aventis U.S. LLC
isatuximab
Sanofi-Aventis U.S. LLC
isatuximab
Sanofi-Aventis U.S. LLC
isatuximab-irfc
Sanofi-Aventis U.S. LLC
clopidogrel
Sanofi-Aventis U.S. LLC
clopidogrel
Sanofi-Aventis U.S. LLC
Primaquine Phosphate
sanofi-aventis U.S. LLC
sodium ferric gluconate complex
sanofi-aventis U.S. LLC
sodium ferric gluconate complex
Sanofi-Aventis U.S. LLC
Dronedarone
Sanofi-Aventis U.S. LLC
Fexinidazole
Sanofi-Aventis U.S. LLC
rasburicase
Sanofi-Aventis U.S. LLC
rasburicase
Sanofi-Aventis U.S. LLC
zolpidem tartrate
Sanofi-Aventis U.S. LLC
insulin glargine and lixisenatide
Sanofi-Aventis U.S. LLC
cabazitaxel
sanofi-aventis U.S. LLC
ziv-aflibercept
sanofi-aventis U.S. LLC
ziv-aflibercept
Sanofi-Aventis U.S. LLC
irbesartan
Sanofi-Aventis U.S. LLC
irbesartan
Sanofi-Aventis U.S. LLC
irbesartan and hydrochlorothiazide
Sanofi-Aventis U.S. LLC
irbesartan and hydrochlorothiazide
Sanofi-Aventis U.S. LLC
PLERIXAFOR
Sanofi-Aventis U.S. LLC
insulin glargine
Sanofi-Aventis U.S. LLC
insulin glargine
Sanofi-Aventis U.S. LLC
alirocumab
Sanofi-Aventis U.S. LLC
alirocumab
Sanofi-Aventis U.S. LLC
sarilumab
Sanofi-Aventis U.S. LLC
sarilumab
Sanofi-Aventis U.S. LLC
Dupilumab
Sanofi-Aventis U.S. LLC
Dupilumab
Sanofi-Aventis U.S. LLC
Dupilumab
Sanofi-Aventis U.S. LLC
Dupilumab
Sanofi-Aventis U.S. LLC
sarilumab
Sanofi-Aventis U.S. LLC
sarilumab
Sanofi-Aventis U.S. LLC
insulin lispro
Sanofi-Aventis U.S. LLC
insulin lispro
Sanofi-Aventis U.S. LLC
insulin lispro
Sanofi-Aventis U.S. LLC
insulin aspart-szjj
Sanofi-Aventis U.S. LLC
insulin aspart-szjj
Sanofi-Aventis U.S. LLC
rifampicin
81 records. Showing 1-40. Next